🏠
Author: elaineywchen.bsky.social (did:plc:vodigzzcsftos5bkavjoazup)

Collections

RecordπŸ€”

uri:
"at://did:plc:vodigzzcsftos5bkavjoazup/app.bsky.feed.post/3k42peqpv6d2n"
cid:
"bafyreia6lllxd4cozxti3sroawxukfi5t27uurvz4er4li2nhl5pfp6ku4"
value:
text:
"For one patient, a journey of getting her prior auth for Wegovy approved meant: her doctor's office appealing 3 times, trying a telehealth provider that claimed to have insurance-processing software, and she herself logging over 32 hours on the phone"
$type:
"app.bsky.feed.post"
embed:
$type:
"app.bsky.embed.external"
external:
thumb:
View blob content
$type:
"blob"
mimeType:
"image/jpeg"
size:
600898
title:
"Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle"
description:
"It’s a charge on all fronts by insurance companies to contain the spiraling costs of a new class of weight-loss-inducing drugs, including Ozempic and Wegovy."
langs:
  • "en"
reply:
root:
cid:
"bafyreiegdewukmvyqrin2i2ub6ogq6e2zqj2z5lkekd5gppwizqcu3o2aq"
parent:
cid:
"bafyreifcuvjisocyoquswv5vltata2lfe5bnqumrrjqa4trdb743vrsyem"
createdAt:
"2023-08-03T14:09:51.176Z"